Cargando…

Evaluation of the Effectiveness of the Policy of Holding the Second Dose of Vaccination: Lessons from the Outbreak in Ho Chi Minh City

HIGHLIGHTS: Many low-and-middle-income countries (LMICs) are facing massive delays in the administration of the second and even the first doses of the COVID-19 vaccines. However, the delays in the administration of the second dose could help governments of LMICs administer the first dose of the vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Trang, Vu Thi Thu, Van Truong, Le, Van Dat, Truong, Elsheikh, Randa, Anh, Nguyen Tuan, Thang, Dang Xuan, Thang, Vo Viet, Makram, Abdelrahman M., Huy, Nguyen Tien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967005/
https://www.ncbi.nlm.nih.gov/pubmed/36851172
http://dx.doi.org/10.3390/vaccines11020293
Descripción
Sumario:HIGHLIGHTS: Many low-and-middle-income countries (LMICs) are facing massive delays in the administration of the second and even the first doses of the COVID-19 vaccines. However, the delays in the administration of the second dose could help governments of LMICs administer the first dose of the vaccine on a larger scale. A more than 21-day delay in the administration of the second dose may further improve the efficacy of the first dose. A longer interval between vaccination and COVID-19 is associated with improved saturation of peripheral oxygen (SPO(2)) rates, indicating that a second dose delay can help lower ICU admissions and mortality rates. ABSTRACT: The coronavirus disease 2019 (COVID-19) pandemic has caused a lot of ethical controversy in the equal provision of healthcare, including vaccination. Therefore, our study was designed to assess the impact of Ho Chi Minh City’s policy to hold the second dose of the COVID-19 vaccine. Using a cross-sectional study design to assess low saturation of peripheral oxygen (SPO2) risk based on vaccination status, we included patients who were confirmed to have SARS-CoV-2 and were treated at home. The stepwise method was used to determine participants’ low SPO2 risk-related factors. The average age of the 2836 respondents was 46.43 ± 17.33 (years). Research results have shown that seven factors are related to the low SPO2 status of participants, including age, sneezing, shortness of breath, coughing, and fainting as COVID-19 symptoms, the number of people living with COVID-19, and a history of lung disease. A statistically significant (p = 0.032) finding in this study was that fully vaccinated patients had a 6% lower risk of low SPO2 compared to the first dose less than 21 days group. This result was similar in the vaccine holder group (p < 0.001). Holding the second dose of the COVID-19 vaccine is associated with a lower SPO2 risk than that of fully vaccinated patients. Therefore, this approach should be considered by governments as it could bring a greater benefit to the community.